NEW CASTLE, Del., April 15, 2013 (GLOBE NEWSWIRE) -- ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, announced today that The Wall Street Analyst recently conducted an audio interview with the Company's Chief Executive Officer, Bob Schneiderman.
The interview can be found on The Wall Street Analyst website at the following link: http://thewallstreetanalysts.com/scipsamerica-inc-otcbbscrc-ceo-interview/
Topics discussed by Mr. Schneiderman include significant anticipated developments for ScripsAmerica in 2013 such as the launch of its RapiMed® children's pain and fever reliever and the acquisition of its pharmaceutical repackager being finalized. He also commented on ScripsAmerica's history, recent revenue growth and why he believes ScripsAmerica's stock is undervalued.
The Wall Street Analyst conducts unbiased, unfiltered and candid interviews with management of publicly traded companies to unlock possible investment opportunities before the rest of the market discovers them. The WSA's staff of writers, analysts, publishers, producers, market researchers and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock and its audience consists of retail and institutional investors, analysts, fund managers and members of the financial press. For more information, visit www.thewallstreetanalysts.com.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. delivers pharmaceutical products to a wide range of end users across the health care industry through the largest pharmaceutical distributor in North America, McKesson Corporation. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. Current therapeutic categories serviced by the Company include pain, arthritis, prenatal, urinary, and hormonal replacement drugs. Other customers of ScripsAmerica include Cardinal Health, CutisPharma, Inc., MedVet and the United States Veterans Administration.
For more information, visit www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT: 888-959-7095Source:ScripsAmerica, Inc.